Lymphocytic and collagenous colitis in children and adolescents: Comprehensive clinicopathologic analysis with long-term follow-up.
Adolescent
Age Factors
Biopsy
CTLA-4 Antigen
/ genetics
Child
Child, Preschool
Colitis, Collagenous
/ complications
Colitis, Lymphocytic
/ complications
Colon
/ immunology
Colonoscopy
DNA Mutational Analysis
Databases, Factual
Female
Genetic Predisposition to Disease
Humans
Male
Mutation
Prognosis
Risk Assessment
Risk Factors
Time Factors
Collagenous colitis
Inflammatory bowel disease
Lymphocytic colitis
Microscopic colitis
Pediatrics
Journal
Human pathology
ISSN: 1532-8392
Titre abrégé: Hum Pathol
Pays: United States
ID NLM: 9421547
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
received:
10
08
2020
revised:
20
09
2020
accepted:
21
09
2020
pubmed:
30
9
2020
medline:
30
3
2021
entrez:
29
9
2020
Statut:
ppublish
Résumé
Microscopic colitis (MC) is characterized by chronic watery diarrhea, endoscopically normal findings, and abnormal histology. While mostly encountered in adults, pediatric cases are rare and may show varying presentations. Our pathology data system was searched from 1984 to 2019 for patients ≤18 years of age with a lymphocytic colitis (LC) or collagenous colitis (CC) pattern of injury. Twenty-seven cases (23 LC and 4 CC) were retrieved. LC was more prevalent than CC (85% vs 15%, respectively) and affected slightly younger individuals (mean, 9.8 years versus 12.25 years). Immune dysregulation was documented in 11 (41%) patients. Most patients presented with watery diarrhea (n = 26, 96%) and either abdominal pain (n = 18, 67%), nausea/vomiting (n = 5, 19%), flatulence (n = 6, 22%), and/or weight loss (n = 1, 4%). A subset of patients (n = 10, 37%) demonstrated endoscopic abnormalities. Histologically, some patients with LC and CC displayed focal cryptitis or crypt abscess formation (n = 7, 26%) and focally increased crypt apoptosis (n = 9, 33%) in the absence of chronic injury. Clinical follow-up data were available for 23 (85%) patients with variable clinical responses recorded. Only 8 patients experienced complete symptom resolution. Twelve patients (11 LC and 1 CC) had subsequent biopsy material; of which, one developed histologic features of inflammatory bowel disease and another was found to have a CTLA-4 deficiency. Our study shows that pediatric patients with MC may have atypical clinical, histologic, and endoscopic findings and variable clinical responses. Underlying inflammatory and/or genetic conditions may be eventually unmasked, and genetic testing may be helpful in a small subset of patients.
Identifiants
pubmed: 32991931
pii: S0046-8177(20)30183-0
doi: 10.1016/j.humpath.2020.09.011
pii:
doi:
Substances chimiques
CTLA-4 Antigen
0
CTLA4 protein, human
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
13-22Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.